Clinical Trial Update: Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Tripley monoclonal antibody combined with GEMOX as first-line treatment for advanced biliary tract tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• GEMOX regimen
• Tripley monoclonal antibody

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Advanced Biliary Tract Tumors | Phase 2 | Status: UNKNOWN